Anbio Biotechnology Cl A (NNNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,403 | N/A | 2,373 | 2,254 | 10,011 |
| Other Working Capital | -13,211 | N/A | 45 | -1,204 | -5,530 |
| Other Operating Activity | 69 | 0 | -338 | -152 | -32 |
| Operating Cash Flow | $-6,739 | $N/A | $2,080 | $898 | $4,449 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -4,202 | 0 | 337 | 1,730 | -1,528 |
| Investing Cash Flow | $-4,202 | $N/A | $337 | $1,730 | $-1,528 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 6,947 | 0 | -345 | -43 | 0 |
| Financing Cash Flow | $6,947 | $N/A | $-345 | $-43 | $0 |
| Beginning Cash Position | 11,761 | N/A | 9,688 | 7,102 | 4,181 |
| End Cash Position | 7,767 | N/A | 11,761 | 9,688 | 7,102 |
| Net Cash Flow | $-3,994 | $N/A | $2,073 | $2,586 | $2,921 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,739 | N/A | 2,080 | 898 | 4,449 |
| Free Cash Flow | -6,739 | 0 | 2,080 | 898 | 4,449 |